The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of the body, shipped to a specialized facility, genetically reprogrammed, ...

Researchers have built DNA-based nanodevices that can identify cancer cells, latch onto them, and deliver drugs or ...

Scientists have developed a method to reprogram cancer-fighting immune cells directly inside the body, potentially ...

Mount Sinai researchers have published the first organ-wide human skin spatial atlas from across the body. It provides an ...

Cancer treatment has long been haunted by the same problem: how do you strike dangerous cells without hitting healthy ones ...

A breakthrough in CAR-T therapy may allow cancer treatment with a single injection, cutting costs and making care more available.

How can cancer cells be targeted without damaging healthy tissue? This is one of the major challenges facing oncology today.

Our immune system relies on T cells to fight infections. But T cells don't just show up and react—first, they train, get a game plan, and coordinate their defenses in lymphoid organs. Researchers have ...

Scientists uncover a metabolic vulnerability in aging cells that could be key to restoring resilience and combating ...

Researchers in Brazil have developed a graphene-based scaffold derived from industrial waste that attracted bone cells and ...